Cargando…

Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications

BACKGROUND: Good glycemic control can delay the progression of kidney diseases in type 2 diabetes mellitus (T2DM) patients with renal complications. To date, the association between antidiabetic agents and glycemic control in this specific patient population is not well established. PURPOSE: This st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huri, Hasniza Zaman, Lim, Lay Peng, Lim, Soo Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535549/ https://www.ncbi.nlm.nih.gov/pubmed/26300627 http://dx.doi.org/10.2147/DDDT.S85676

Ejemplares similares

Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia
por: Zaman Huri, Hasniza, et al.
Publicado: (2013)

Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
por: Lin, Shu Ning, et al.
Publicado: (2020)

Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2015)

Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study
por: Zaman Huri, Hasniza, et al.
Publicado: (2013)

Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Syed Ikmal, Sharifah Intan Qhadijah, et al.
Publicado: (2013)

Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2016)

Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2017)

Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2019)

Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2023)

Drug-related problems in patients with rheumatoid arthritis
por: Ma, Shu Ning, et al.
Publicado: (2019)

Retinol-Binding Protein-4—A Predictor of Insulin Resistance and the Severity of Coronary Artery Disease in Type 2 Diabetes Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2021)

Single Nucleotide Polymorphism rs17173608 in the Chemerin Encoding Gene: Is It a Predictor of Insulin Resistance and Severity of Coronary Artery Disease in Non-Obese Type 2 Diabetes?
por: Perumalsamy, Sangeetha, et al.
Publicado: (2021)

Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2019)

Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review
por: Almualm, Yasmin, et al.
Publicado: (2015)

Drug-related problems in patients with erectile dysfunctions and multiple comorbidities
por: Huri, Hasniza Zaman, et al.
Publicado: (2017)

Differences in glycemic control across world regions: a post-hoc analysis in patients with type 2 diabetes mellitus on dual antidiabetes drug therapy
por: Brath, H, et al.
Publicado: (2016)

Periodontal disease and type I diabetes mellitus: Associations with glycemic control and complications
por: Meenawat, Ajita, et al.
Publicado: (2013)

Association of MG53 with presence of type 2 diabetes mellitus, glycemic control, and diabetic complications
por: Andaç, Burak, et al.
Publicado: (2023)

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
por: Chaudhury, Arun, et al.
Publicado: (2017)

Factors that Correlate with Poor Glycemic Control in Type 2 Diabetes Mellitus Patients with Complications
por: Haghighatpanah, Mohammad, et al.
Publicado: (2018)

The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus
por: Bijelic, Radojka, et al.
Publicado: (2020)

Changes in Antidiabetic Drug Prescription and Glycemic Control Trends in Elderly Patients with Type 2 Diabetes Mellitus from 2005-2013: An Analysis of the National Center Diabetes Database (NCDD-03)
por: Yamamoto-Honda, Ritsuko, et al.
Publicado: (2017)

Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention
por: Mokhtar, Fadzlin Mohd, et al.
Publicado: (2021)

Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes
por: Tan, Eleonora, et al.
Publicado: (2015)

Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
por: Ruiz-Tamayo, Irene, et al.
Publicado: (2016)

Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
por: Liu, Wenhui, et al.
Publicado: (2022)

Predictors of poor glycemic control among type 2 diabetes mellitus patients treated with antidiabetic medications: A cross-sectional study in China
por: Wang, Jingqing, et al.
Publicado: (2021)

Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
por: Tee, Khim Boon, et al.
Publicado: (2022)

Factors affecting glycemic control in diabetes mellitus complicated by autoimmune pancreatitis
por: Harai, Nozomi, et al.
Publicado: (2022)

Cardiovascular Outcomes with Finerenone According to Glycemic Status at Baseline and Prior Treatment with Newer Antidiabetics among Patients with Type 2 Diabetes Mellitus
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Frequency of Depression in Patients with Type 2 Diabetes Mellitus and its Relationship with Glycemic Control and Diabetic Microvascular Complications
por: Sharif, Sabira, et al.
Publicado: (2019)

Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus
por: Kong, Sung Hye, et al.
Publicado: (2019)

Ferritin levels in children and adolescents with type 1 diabetes mellitus: relationship with microvascular complications and glycemic control
por: Metwalley, Kotb Abbass, et al.
Publicado: (2020)

Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach to Management of Anaemia in Chronic Kidney Disease
por: Yugavathy, Nava, et al.
Publicado: (2023)

Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
por: Ha, Jeonghoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n7iq4g8dfsdr7q9bocekrfsnpt